NuCana PLC (NCNA)
4.00
+0.04
(+0.88%)
USD |
NASDAQ |
May 03, 16:00
4.00
0.00 (0.00%)
After-Hours: 20:00
NuCana Price to Book Value: 0.4460 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 02, 2024 | 0.4421 |
May 01, 2024 | 0.4437 |
April 30, 2024 | 0.4415 |
April 29, 2024 | 0.446 |
April 26, 2024 | 0.446 |
April 25, 2024 | 0.4248 |
April 24, 2024 | 0.4281 |
April 23, 2024 | 0.446 |
April 22, 2024 | 0.4449 |
April 19, 2024 | 0.4209 |
April 18, 2024 | 0.4226 |
April 17, 2024 | 0.4426 |
April 16, 2024 | 0.4348 |
April 15, 2024 | 0.4961 |
April 12, 2024 | 0.6241 |
April 11, 2024 | 0.6595 |
April 10, 2024 | 0.6595 |
April 09, 2024 | 0.6617 |
April 08, 2024 | 0.6578 |
April 05, 2024 | 0.6486 |
April 04, 2024 | 0.667 |
April 03, 2024 | 0.7311 |
April 02, 2024 | 0.6405 |
April 01, 2024 | 0.6606 |
March 28, 2024 | 0.7247 |
Date | Value |
---|---|
March 27, 2024 | 0.8547 |
March 26, 2024 | 0.8529 |
March 25, 2024 | 0.8747 |
March 22, 2024 | 0.8476 |
March 21, 2024 | 0.8075 |
March 20, 2024 | 0.9273 |
March 19, 2024 | 0.9321 |
March 18, 2024 | 1.023 |
March 15, 2024 | 0.9719 |
March 14, 2024 | 1.089 |
March 13, 2024 | 1.171 |
March 12, 2024 | 1.072 |
March 11, 2024 | 0.9198 |
March 08, 2024 | 0.9237 |
March 07, 2024 | 0.9198 |
March 06, 2024 | 0.8983 |
March 05, 2024 | 0.917 |
March 04, 2024 | 0.9198 |
March 01, 2024 | 0.8919 |
February 29, 2024 | 0.8919 |
February 28, 2024 | 0.9151 |
February 27, 2024 | 0.9181 |
February 26, 2024 | 0.9187 |
February 23, 2024 | 0.8641 |
February 22, 2024 | 0.9407 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3978
Minimum
May 31 2022
5.049
Maximum
May 06 2019
1.631
Average
1.345
Median
Oct 18 2021
Price to Book Value Benchmarks
Adaptimmune Therapeutics PLC | 7.465 |
Biodexa Pharmaceuticals Plc | 0.8756 |
Autolus Therapeutics PLC | 9.984 |
Mereo BioPharma Group PLC | 9.062 |
Bicycle Therapeutics PLC | 2.513 |
Price to Book Value Related Metrics
Price | 4.00 |
Earnings Yield | -411.5% |
Market Cap | 8.458M |